vs

Side-by-side financial comparison of ASSEMBLY BIOSCIENCES, INC. (ASMB) and Local Bounti Corporation (LOCL). Click either name above to swap in a different company.

Local Bounti Corporation is the larger business by last-quarter revenue ($12.5M vs $10.8M, roughly 1.2× ASSEMBLY BIOSCIENCES, INC.). Local Bounti Corporation runs the higher net margin — -69.8% vs -85.2%, a 15.4% gap on every dollar of revenue. On growth, ASSEMBLY BIOSCIENCES, INC. posted the faster year-over-year revenue change (57.6% vs 23.7%). Local Bounti Corporation produced more free cash flow last quarter ($-3.6M vs $-15.2M).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.

ASMB vs LOCL — Head-to-Head

Bigger by revenue
LOCL
LOCL
1.2× larger
LOCL
$12.5M
$10.8M
ASMB
Growing faster (revenue YoY)
ASMB
ASMB
+33.9% gap
ASMB
57.6%
23.7%
LOCL
Higher net margin
LOCL
LOCL
15.4% more per $
LOCL
-69.8%
-85.2%
ASMB
More free cash flow
LOCL
LOCL
$11.5M more FCF
LOCL
$-3.6M
$-15.2M
ASMB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASMB
ASMB
LOCL
LOCL
Revenue
$10.8M
$12.5M
Net Profit
$-9.2M
$-8.7M
Gross Margin
12.2%
Operating Margin
-100.9%
-106.1%
Net Margin
-85.2%
-69.8%
Revenue YoY
57.6%
23.7%
Net Profit YoY
4.3%
76.0%
EPS (diluted)
$-0.72
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASMB
ASMB
LOCL
LOCL
Q4 25
$12.5M
Q3 25
$10.8M
$12.2M
Q2 25
$9.6M
$12.1M
Q1 25
$9.4M
$11.6M
Q4 24
$7.4M
$10.1M
Q3 24
$6.8M
$10.2M
Q2 24
$8.5M
$9.4M
Q1 24
$5.8M
$8.4M
Net Profit
ASMB
ASMB
LOCL
LOCL
Q4 25
$-8.7M
Q3 25
$-9.2M
$-26.4M
Q2 25
$-10.2M
$-21.6M
Q1 25
$-8.8M
$-37.7M
Q4 24
$-36.3M
Q3 24
$-9.6M
$-34.3M
Q2 24
$-11.2M
$-25.3M
Q1 24
$-9.1M
$-24.1M
Gross Margin
ASMB
ASMB
LOCL
LOCL
Q4 25
12.2%
Q3 25
11.5%
Q2 25
12.2%
Q1 25
12.6%
Q4 24
5.4%
Q3 24
13.8%
Q2 24
14.3%
Q1 24
9.4%
Operating Margin
ASMB
ASMB
LOCL
LOCL
Q4 25
-106.1%
Q3 25
-100.9%
-149.4%
Q2 25
-115.2%
-127.7%
Q1 25
-105.5%
-135.6%
Q4 24
-166.6%
Q3 24
-160.1%
-176.0%
Q2 24
-143.0%
-146.8%
Q1 24
-185.5%
-122.9%
Net Margin
ASMB
ASMB
LOCL
LOCL
Q4 25
-69.8%
Q3 25
-85.2%
-216.6%
Q2 25
-105.9%
-178.3%
Q1 25
-93.6%
-324.6%
Q4 24
-360.1%
Q3 24
-140.4%
-335.2%
Q2 24
-130.7%
-267.6%
Q1 24
-156.9%
-286.9%
EPS (diluted)
ASMB
ASMB
LOCL
LOCL
Q4 25
$1.52
Q3 25
$-0.72
$-1.18
Q2 25
$-1.33
$-1.63
Q1 25
$-1.17
$-4.32
Q4 24
$-4.24
Q3 24
$-1.51
$-4.01
Q2 24
$-1.98
$-3.00
Q1 24
$-1.66
$-2.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASMB
ASMB
LOCL
LOCL
Cash + ST InvestmentsLiquidity on hand
$22.5M
$4.2M
Total DebtLower is stronger
$483.1M
Stockholders' EquityBook value
$182.7M
$-166.2M
Total Assets
$240.0M
$410.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASMB
ASMB
LOCL
LOCL
Q4 25
$4.2M
Q3 25
$22.5M
$6.2M
Q2 25
$24.0M
$5.3M
Q1 25
$23.4M
$18.0M
Q4 24
$38.3M
$937.0K
Q3 24
$28.5M
$317.0K
Q2 24
$19.2M
$9.7M
Q1 24
$18.7M
$8.2M
Total Debt
ASMB
ASMB
LOCL
LOCL
Q4 25
$483.1M
Q3 25
$484.9M
Q2 25
$478.3M
Q1 25
$480.0M
Q4 24
$436.8M
Q3 24
$398.4M
Q2 24
$374.0M
Q1 24
$329.8M
Stockholders' Equity
ASMB
ASMB
LOCL
LOCL
Q4 25
$-166.2M
Q3 25
$182.7M
$-158.1M
Q2 25
$18.1M
$-132.7M
Q1 25
$27.1M
$-134.5M
Q4 24
$33.4M
$-100.5M
Q3 24
$26.0M
$-65.6M
Q2 24
$34.7M
$-32.8M
Q1 24
$32.6M
$-9.4M
Total Assets
ASMB
ASMB
LOCL
LOCL
Q4 25
$410.5M
Q3 25
$240.0M
$417.8M
Q2 25
$80.8M
$426.8M
Q1 25
$99.0M
$447.2M
Q4 24
$119.2M
$428.0M
Q3 24
$100.3M
$430.8M
Q2 24
$115.3M
$438.1M
Q1 24
$119.9M
$413.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASMB
ASMB
LOCL
LOCL
Operating Cash FlowLast quarter
$-15.1M
$-3.1M
Free Cash FlowOCF − Capex
$-15.2M
$-3.6M
FCF MarginFCF / Revenue
-140.7%
-29.1%
Capex IntensityCapex / Revenue
0.4%
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASMB
ASMB
LOCL
LOCL
Q4 25
$-3.1M
Q3 25
$-15.1M
$-8.9M
Q2 25
$-16.8M
$-8.7M
Q1 25
$-23.4M
$-9.6M
Q4 24
$-51.1M
$1.2M
Q3 24
$-15.2M
$-17.2M
Q2 24
$-17.1M
$-4.0M
Q1 24
$-18.4M
$-7.1M
Free Cash Flow
ASMB
ASMB
LOCL
LOCL
Q4 25
$-3.6M
Q3 25
$-15.2M
$-10.1M
Q2 25
$-14.6M
Q1 25
$-14.5M
Q4 24
$-51.1M
$-8.6M
Q3 24
$-30.0M
Q2 24
$-17.1M
$-28.8M
Q1 24
$-18.4M
$-42.1M
FCF Margin
ASMB
ASMB
LOCL
LOCL
Q4 25
-29.1%
Q3 25
-140.7%
-82.8%
Q2 25
-121.0%
Q1 25
-125.1%
Q4 24
-695.2%
-85.3%
Q3 24
-293.1%
Q2 24
-200.6%
-305.4%
Q1 24
-317.7%
-501.8%
Capex Intensity
ASMB
ASMB
LOCL
LOCL
Q4 25
3.9%
Q3 25
0.4%
9.7%
Q2 25
0.0%
48.9%
Q1 25
0.0%
42.8%
Q4 24
0.4%
97.6%
Q3 24
0.0%
125.0%
Q2 24
0.2%
263.0%
Q1 24
0.2%
417.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons